''Drug and medical device company Covidien said Nov. 9 that it is changing the label of its imaging agent Optimark to indicate that it is dangerous for use in patients with severe renal impairment. Optimark gadoversetamide injection is a ...'
Wednesday, 11 November 2009 by www.renalbusiness.com
Remember not only to say the right thing in the right place, but far more
difficult still, to leave unsaid the wrong thing at the tempting moment. -
Benjamin Franklin
•
News
top
